Article thumbnail

Hepatic manifestations of celiac disease

By Hugh James Freeman

Abstract

Different hepatic and biliary tract disorders may occur with celiac disease. Some have been hypothesized to share genetic or immunopathogenetic factors, such as primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Other hepatic changes in celiac disease may occur with malnutrition resulting from impaired nutrient absorption, including hepatic steatosis. In addition, celiac disease may be associated with rare hepatic complications, such as hepatic T-cell lymphoma

Topics: Review
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3108670
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. a newly discovered modulator of intestinal permeability, and its expression in celiac disease.
  2. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
  3. A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy, and necrotizing hepatitis.
  4. (2006). Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci.
  5. Acute mesenteric ischemia: a presenting feature of celiac disease?
  6. Adult celiac disease and hemochromatosis.
  7. Adult celiac disease and primary biliary cirrhosis.
  8. Adult celiac disease and primary sclerosing cholangitis: two case reports.
  9. Adult celiac disease, small and medium vessel cutaneous necrotizing vasculitis, and T cell lymphoma. J Am Acad Dermatol.
  10. (1979). An association between primary biliary cirrhosis and jejunal villous atrophy resembling celiac disease. Dig Dis Sci.
  11. Association of hepatic vein obstruction and celiac disease in North African subjects.
  12. (2004). Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig Dis Sci.
  13. Association of primary sclerosis cholangitis, ulcerative colitis, and celiac disease in female siblings.
  14. Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature.
  15. (2005). Autoimmune cholestatic liver disease in people with celiac disease: a population-based study of their association. Aliment Pharmacol Ther.
  16. (2004). Budd-Chiari syndrome caused by membranous obstruction of the inferior vena cava associated with celiac disease. Dig Liver Dis.
  17. Budd-Chiari syndrome in children: report of 22 cases.
  18. Celiac disease and hereditary hemochromatosis: association and implications.
  19. (2007). Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol.
  20. (2009). Celiac disease as a potential cause of idiopathic portal hypertension: a case report. J Med Case Reports.
  21. (1994). Celiac disease associated with primary cirrhosis in a Coast Salish native.
  22. (2004). Celiac disease associated with Sjogren’s syndrome, renal tubular acidosis, primary biliary cirrhosis, and autoimmune hyperthyroidism. Dig Liver Dis.
  23. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation.
  24. Celiac disease hidden by cryptogenic hypertransaminasemia.
  25. Celiac disease in autoimmune cholestatic liver disorders.
  26. (2007). Celiac disease in chronic hepatitis C: a French multicentre prospective study. Aliment Pharmacol Ther.
  27. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.
  28. (2007). Celiac disease is not associated with chronic hepatitis C. Dig Dis Sci.
  29. (1998). Celiac disease of the adult following orthotopic liver transplantation. Description of a case. Gastroenterol Hepatol.
  30. Celiac disease, chronic active hepatitis, and mesangiocapillary glomerulonephritis in the same patient.
  31. Celiac disease, vasculitis, and cryoglobulinemia.
  32. Celiac disease: from pathogenesis to novel therapies.
  33. (2002). Celiac diseaseassociated autoimmune cholangitis.
  34. Celiac sprue: another autoimmune syndrome associated with hepatitis C.
  35. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.
  36. (1990). Colonic lymphocytosis in patients with celiac sprue. Hum Pathol.
  37. Cutaneous vasculitis as a mani festation of celiac disease.
  38. Discussion of the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac disease.
  39. End-stage primary biliary cirrhosis in a first generation migrant Asian population.
  40. (1972). Fatty liver and malabsorption. Folia Med Neerl.
  41. (1998). Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci.
  42. Fulminant liver failure with necrotizing foci in the liver, spleen, and lymph nodes in celiac disease due to malignant lymphoma.
  43. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.
  44. (1990). Hemiplegia revealing Budd-Chiari syndrome associated with celiac disease in an infant. Presse Med.
  45. Hemochromatosis and celiac sprue. Case report.
  46. Hemochromatosis gene mutations and iron metabolism in celiac disease.
  47. Hepatic damage in celiac disease in childhood. Minerva Pediatr.
  48. Hepatic effects of jejunoileal bypass for morbid obesity.
  49. Hepatic injury in adult celiac disease.
  50. Hepatic lesions in adult celiac disease.
  51. (1976). Hepatobiliary disorders in inflammatory bowel disease. Prog Liver Dis.
  52. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma-delta.
  53. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue transglutaminase autoantibodies.
  54. High prevalence of celiac sprue among patients with primary biliary cirrhosis.
  55. (1997). Identification of tissue transglutaminase as the auto-antigen of celiac disease. Nat Med.
  56. (2003). IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci.
  57. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.
  58. Infectious associations of celiac disease.
  59. Intestinal villous atrophy in chronic active hepatitis.
  60. Is celiac disease a potentially treatable cause of liver failure?
  61. Liver abnormalities associated with celiac sprue. How common are they, what is their significance, and what do we do about them?
  62. (2006). Liver dysfunction after a gluten-free diet in a patient with celiac disease: a new link? Dig Dis Sci.
  63. Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease.
  64. Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease.
  65. Massive hepatic steatosis complicating adult celiac disease: report of a case and review of the literature.
  66. Massive hepatic steatosis disclosing adult celiac disease: report of a case and review of the literature.
  67. Non-thyroid autoantibodies in autoimmune thyroid disease.
  68. Nonalcoholic steatohepatitis, obesity, and celiac disease.
  69. Occult celiac disease associated with lymphocytic sclerosing cholangitis.
  70. (2005). Occult celiac disease prevents penetrance of hemochromatosis. World
  71. On the concurrence of primary biliary cirrhosis and intestinal villous atrophy.
  72. (2009). Pathogenesis and clinical significance of liver injury in celiac disease. Clin Rev Allergy Immunol.
  73. Plasma amino acids in children from Guadalajara with kwashiorkor.
  74. (2000). Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease.
  75. (2002). Prevalence of celiac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult celiac disease patients in Italy. Dig Liver Dis.
  76. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet.
  77. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.
  78. Primary biliary cirrhosis and celiac disease: an association?
  79. Primary sclerosing cholangitis and celiac disease. A novel association.
  80. Protein digestion and absorption. Normal mechanisms and protein-energy malnutrition.
  81. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity.
  82. Renal tubular acidosis in association with Sjogren’s syndrome, primary biliary cirrhosis, and celiac disease.
  83. Risk of primary biliary cirrhosis in patients with celiac disease: Danish and Swedish cohort data.
  84. Serological testing in screening for adult celiac disease.
  85. Severe liver damage associated with celiac disease: findings in six toddler-aged girls.
  86. Should routine screening for celiac disease be considered before starting interferon/ ribavirin treatment in patients affected by chronic hepatitis C?
  87. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on disease onset and clinical outcome.
  88. Solid-phase ELISA for tissue transglutaminase, an endomysial target for possible serological diagnosis of celiac disease.
  89. The association between primary biliary cirrhosis and celiac disease: a study of relative prevalences.
  90. The celtic coincidence – the frequency and clinical characterization of hereditary hemochromatosis in patients with celiac disease.
  91. The liver in celiac disease.
  92. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.
  93. (2004). Transcriptional downregulation of tight junction protein ZO-1 in active celiac disease is reversed after a gluten-free diet. Dig Liver Dis.
  94. Ulcerative colitis, primary sclerosing cholangitis and celiac disease: two cases and review of the literature.